Medycyna Paliatywna-Palliative Medicine is a vital academic journal dedicated to advancing the field of palliative care, published by TERMEDIA PUBLISHING HOUSE LTD. With its ISSN 2081-0016 and E-ISSN 2081-2833, this journal serves as a reputable source of high-quality research and compelling insights for scholars, healthcare professionals, and students committed to improving the quality of life for patients with serious illnesses. Although it does not currently offer Open Access, Medycyna Paliatywna ensures that articles published within its pages undergo rigorous peer review, reflecting the highest standards in medical research. The journal aims to contribute to the ongoing dialogue in palliative medicine, encouraging innovative practices, sharing evidence-based strategies, and fostering collaboration among healthcare providers. By disseminating important findings and clinical insights, Medycyna Paliatywna plays a crucial role in shaping the future direction of palliative care, making it an essential resource for anyone involved in this critical field.

ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.

Neuro-Oncology Practice is a leading journal in the interdisciplinary field of neuro-oncology, published by Oxford University Press. With an ISSN of 2054-2577 and E-ISSN 2054-2585, this journal provides a critical platform for the dissemination of cutting-edge research and clinical advancements since its inception in 2014. As of 2023, it has achieved a Q2 ranking in Medicine (Miscellaneous), Neurology, and Oncology categories, reflecting its esteemed position in the academic community with impressive Scopus rankings, including a 74th percentile in the field of Medicine. Despite its non-open access status, Neuro-Oncology Practice aims to bridge the gap between laboratory research and clinical practice, offering valuable insights for professionals involved in the treatment and study of neurological cancers. The journal actively encourages submissions that explore innovative treatment strategies, enhance patient care, and advance our understanding of the complexities surrounding brain tumors. With a convergence period extending to 2024, it remains a crucial resource for researchers, practitioners, and students who are committed to improving outcomes in the field of neuro-oncology.

Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

PROGRESS IN PALLIATIVE CARE, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing the field of palliative care through high-quality research and innovative practices. With an ISSN of 0969-9260 and an E-ISSN of 1743-291X, this journal serves as a critical resource for healthcare professionals, researchers, and students seeking to enhance their understanding of pain management, symptom relief, and holistic care approaches for patients with life-limiting illnesses. Operating without an open access model, the journal is well-regarded in the academic community, holding a Q3 ranking in Medicine (miscellaneous) and a Q2 ranking in Nursing (miscellaneous) as of 2023. Its Scopus ranking places it at rank #51 out of 139 in General Nursing, reflecting its relevance and quality within the field. Covering the period from 2001 to 2024, it aims to foster interdisciplinary dialogue and share vital research findings to improve palliative care practices, ultimately enhancing patient care and outcomes.

Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

Frontiers in Oncology is a premier open access journal dedicated to advancing the field of oncology through innovative research and knowledge dissemination. Published by FRONTIERS MEDIA SA since 2011, this journal is based in Switzerland and holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, highlighting its significance in the academic community. With its commitment to open access, Frontiers in Oncology ensures that vital research is readily available to researchers, healthcare professionals, and students around the globe, enhancing collaboration and fostering breakthroughs in cancer research. The journal's robust Scopus rankings further illustrate its academic influence, with notable positions in the fields of Oncology and Cancer Research. By covering a wide range of topics within oncology, this journal serves as a vital resource, supporting the rapid evolution of cancer treatment, diagnostics, and patient care strategies.

Palliative Medicine is a premier journal dedicated to advancing the field of palliative care, published by SAGE Publications Ltd. Established in 1987 and continuing through 2024, this esteemed journal focuses on the integration of pain management and comprehensive care for patients with life-limiting illnesses. With its impressive impact factor and a prestigious Q1 ranking in both Anesthesiology and Pain Medicine, as well as in Medicine (miscellaneous), it stands as a critical resource for researchers, healthcare professionals, and students engaged in this vital area of medicine. The journal emphasizes original research, reviews, and clinical studies that contribute to the understanding and practice of palliative care, promoting improved quality of life and support for patients and their families. Although not open access, articles are accessible through institutional subscriptions, ensuring the dissemination of knowledge to a wide audience. Whether you are a seasoned researcher or an emerging professional in the field, Palliative Medicine remains an invaluable platform for scholarly exchange and innovation.

INTENSIVE CARE MEDICINE is a premier academic journal in the field of critical care and intensive care medicine, published by SPRINGER. With an impressive HIndex and a remarkable impact factor, this journal consistently ranks in the top quartile of its category, achieving Q1 status for 2023. Spanning over four decades since its inception in 1977, it serves as a crucial platform for disseminating groundbreaking research and clinical advancements that shape the future of intensive care. Notably, it holds a distinguished position in the Scopus rankings, placed #1 out of 110 in its field, reflecting its importance and influence among researchers and clinicians alike. Although it is not an open-access journal, it offers various subscription options, ensuring wide accessibility to its high-quality content. The journal is dedicated to enhancing knowledge and practices within the critical care community, making it an indispensable resource for practitioners, researchers, and students pursuing excellence in intensive care medicine.